The experimental study of the immunomodulating action of Semax and Selank on the model of „social” stress

[1] Akmaev IG. Neuroimmunoendocrinology: sources and prospects of development. Succ Physiol Sci. 2003;34/4:4–15. AkmaevIG Neuroimmunoendocrinology: sources and prospects of development Succ Physiol Sci 2003 34 4 4 15 Search in Google Scholar

[2] Ashmarin IP, Koroleva SV. Regularities of interaction and functional continuum of neuropeptides (on the way to a unified concept): Overview. Bull Rus Acad Med Sci..2002;6:40–48. AshmarinIP KorolevaSV Regularities of interaction and functional continuum of neuropeptides (on the way to a unified concept): Overview Bull Rus Acad Med Sci 2002 6 40 48 Search in Google Scholar

[3] Ashmarin I.P., Nezavibatko V.N., Myasoedov N.F., Kamensky A.A., Grivennikov I.A., Ponomareva-Stepnaya M.A. et al. Nootropic analogue of adrenocorticotropin 4-10-semax (the experience of design and investigation over 15 years). Journal of Higher Nervous Activity. I. Pavlova. 1997; 47(2): 429–430. AshmarinI.P. NezavibatkoV.N. MyasoedovN.F. KamenskyA.A. GrivennikovI.A. Ponomareva-StepnayaM.A. Nootropic analogue of adrenocorticotropin 4-10-semax (the experience of design and investigation over 15 years) Journal of Higher Nervous Activity. I. Pavlova 1997 47 2 429 430 Search in Google Scholar

[4] Ashmarin IP, Obukhova MF. The current state of the hypothesis of a functional continuum of regulatory peptides. Vestnik RAMN. 1994;10:28–34. AshmarinIP ObukhovaMF The current state of the hypothesis of a functional continuum of regulatory peptides Vestnik RAMN 1994 10 28 34 Search in Google Scholar

[5] Belokrylov GA, Malchanova IV. Levamin and cerebrolysin as immunostimulants. Biull Eksp Biol Med. 1992;113(2):165–6. BelokrylovGA MalchanovaIV Levamin and cerebrolysin as immunostimulants Biull Eksp Biol Med 1992 113 2 165 6 10.1007/BF00791503 Search in Google Scholar

[6] Bulgakova OS. Immunity and various stages of stress effects. Succ Mod Nat Sci. 2011;4:31–35. BulgakovaOS Immunity and various stages of stress effects Succ Mod Nat Sci 2011 4 31 35 Search in Google Scholar

[7] Dolotov OV, Eremin KO, Andreeva LA et al. Semax prevents the death of tyrosine hydroxylase-positive neurons in a mixed neuroglial cell culture derived from the embryonic rat mesencephalon in a model of 6-hydroxydopamine-induced neurotoxicity.. Neurochemistry. 2015;32/4:317–321. DolotovOV EreminKO AndreevaLA Semax prevents the death of tyrosine hydroxylase-positive neurons in a mixed neuroglial cell culture derived from the embryonic rat mesencephalon in a model of 6-hydroxydopamine-induced neurotoxicity Neurochemistry 2015 32 4 317 321 10.1134/S1819712415040066 Search in Google Scholar

[8] Eremin K.O., Kudrin V.S., Rayevsky K.S., Saransaari P., Oja S.S., Grivennikov I.A., Myasoedov N.F. Semax, an ACTH(4–10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochemical Research. 2005; 30(12): 1493–1500. EreminK.O. KudrinV.S. RayevskyK.S. SaransaariP. OjaS.S. GrivennikovI.A. MyasoedovN.F Semax, an ACTH(4–10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents Neurochemical Research 2005 30 12 1493 1500 10.1007/s11064-005-8826-816362768 Search in Google Scholar

[9] Gabbyasova Yu.R., Tret’yakov D.A., Pleten’ A.P. Peptides of the brain (review). New science: current state and development paths. 2017; 3/3:36–41. GabbyasovaYu.R. Tret’yakovD.A. Pleten’A.P. Peptides of the brain (review) New science: current state and development paths 2017 3 3 36 41 Search in Google Scholar

[10] Garmanchuk LV, Perepelitsyna EM, Sidorenko Mv, Makarenko AN, Kul’chikov AE. Cytoprotective effect of neuropeptides on immunocompetent cells (in vitro study). Eksperimental clinical pharmakology. 2009; Jul–Aug;72(4):28–32. GarmanchukLV PerepelitsynaEM SidorenkoMv MakarenkoAN Kul’chikovAE Cytoprotective effect of neuropeptides on immunocompetent cells (in vitro study) Eksperimental clinical pharmakology 2009 Jul–Aug 72 4 28 32 Search in Google Scholar

[11] Gromov L.A. Neuropeptides. Kiev: Zdorov’e; 1992; 245. GromovL.A. Neuropeptides Kiev Zdorov’e 1992 245 Search in Google Scholar

[12] Kolomin T.A., Agapova T. Yu., Agnilullin Ya. V., Shram S.I., Shadrina M.I., Slominskiy P.A. i dr. Change in the transcriptome profile of the hippocampus in response to the introduction of the analog of taftcin selank. Journal of Higher Nervous Activity. I. Pavlova.2013; 63(3): 365–374. KolominT.A. AgapovaT. Yu. AgnilullinYa. V. ShramS.I. ShadrinaM.I. SlominskiyP.A. i dr. Change in the transcriptome profile of the hippocampus in response to the introduction of the analog of taftcin selank Journal of Higher Nervous Activity. I. Pavlova 2013 63 3 365 374 Search in Google Scholar

[13] Kudryavtseva NN. Serotonergic control of aggressive behavior: new approaches - new interpretations (review). J High Nerv Act.(I.P. Pavlova). 2015:65/5:546. KudryavtsevaNN Serotonergic control of aggressive behavior: new approaches - new interpretations (review) J High Nerv Act.(I.P. Pavlova) 2015 65 5 546 Search in Google Scholar

[14] Levitskaya N.G., Glazova N.Yu., Sebentsova E.A., Manchenko D.M., Vilenskiy D.A., Andreeva L.A. Investigation of the spectrum of physiological activity of analogue ACTG4-10 heptapeptide semax. Neurochemistry. 2008; 25(1): 111–118. LevitskayaN.G. GlazovaN.Yu. SebentsovaE.A. ManchenkoD.M. VilenskiyD.A. AndreevaL.A Investigation of the spectrum of physiological activity of analogue ACTG4-10 heptapeptide semax Neurochemistry 2008 25 1 111 118 Search in Google Scholar

[15] Mironov AN, ed. A guide to preclinical drug research. Part One. Moscow, Grief and K; 2012: 944 MironovAN ed. A guide to preclinical drug research. Part One Moscow Grief and K 2012 944 Search in Google Scholar

[16] Perel’muter V.M., Odintsov Yu. N., Kliment’eva T.K. Taftsin is a natural immunomodulator. Possible role in tumor progression. Siberian Journal of Oncology. 2004; 12(4): C. 57–62. Perel’muterV.M. OdintsovYu. N. Kliment’evaT.K. Taftsin is a natural immunomodulator. Possible role in tumor progression Siberian Journal of Oncology 2004 12 4 C. 57 62 Search in Google Scholar

[17] Titov VN. Biological function of stress, congenital immunity, inflammation reaction and arterial hypertension. Clin Lab Diagn. 2008;12:3–16. TitovVN Biological function of stress, congenital immunity, inflammation reaction and arterial hypertension Clin Lab Diagn 2008 12 3 16 Search in Google Scholar

[18] Fedorova OV, Krayushkina NG, Shefer EG. Poststressing modulation of immunogenesis organs. Bull Volg State Med Univ. 2010;3/35:8–12. FedorovaOV KrayushkinaNG SheferEG Poststressing modulation of immunogenesis organs Bull Volg State Med Univ 2010 3 35 8 12 Search in Google Scholar

[19] Khavinson VKh, Kvetnoy IM, Ashmarin IP. Peptidergic regulation of homeostasis. Succ Mod Biol. 2002;122:190–203. KhavinsonVKh KvetnoyIM AshmarinIP Peptidergic regulation of homeostasis Succ Mod Biol 2002 122 190 203 Search in Google Scholar

[20] Khnychenko LK, Sapronov NS. Stress and its role in the development of pathological processes. Rev Clin Pharm Drug Ther. 2003; 2/3:2–15. KhnychenkoLK SapronovNS Stress and its role in the development of pathological processes Rev Clin Pharm Drug Ther 2003 2 3 2 15 Search in Google Scholar

[21] Sever’yanova L.A., Bobyntsev I.I., Kryukov A.A. Neuropeptides and active amino acids: effects on various types of pain sensitivity and pain-induced behavior. Patogenez. 2005; 3(1): 23–24. Sever’yanovaL.A. BobyntsevI.I. KryukovA.A. Neuropeptides and active amino acids: effects on various types of pain sensitivity and pain-induced behavior Patogenez 2005 3 1 23 24 Search in Google Scholar

[22] Skrebitskiy VG, Kasyan AP, Povarov IS, Kondratenko RV, Slominskiy PA. Neuropeptide drug Selank: biological activity and fundamental mechanisms of action. Nerv Dis. 2016; 4:52–56. SkrebitskiyVG KasyanAP PovarovIS KondratenkoRV SlominskiyPA Neuropeptide drug Selank: biological activity and fundamental mechanisms of action Nerv Dis 2016 4 52 56 Search in Google Scholar

[23] Uchakina O.N., Uchakin P.N., Myasoedov N.F., Andreeva L.A., Shcherbenko V.E., Mezentseva M.V. Immunomodulating properties of Selank in people with anxiety-asthenic disorders. Journal of Neurology and Psychiatry. S.S. Korsakov.2008; 5: 71–75. UchakinaO.N. UchakinP.N. MyasoedovN.F. AndreevaL.A. ShcherbenkoV.E. MezentsevaM.V. Immunomodulating properties of Selank in people with anxiety-asthenic disorders Journal of Neurology and Psychiatry. S.S. Korsakov 2008 5 71 75 Search in Google Scholar

[24] Volkova A., Shadrina M., Kolomin T., Andreeva L., Limborska S., Myasoedov N., Slominsky P. Selank administration affects the expression of some genes involved in gabaergic neurotransmission. Frontiers in Pharmacology. 2016; 7: 31. VolkovaA. ShadrinaM. KolominT. AndreevaL. LimborskaS. MyasoedovN. SlominskyP. Selank administration affects the expression of some genes involved in gabaergic neurotransmission Frontiers in Pharmacology 2016 7 31 10.3389/fphar.2016.00031475766926924987 Search in Google Scholar

[25] Deak T, Quinn M, Cidlowski JA, Victoria NC, Murphy AZ, Sheridan JF. Neuroimmune mechanisms of stress: sex differences, developmental plasticity, and implications for stress-related disease. Stress 2015;18(4):367–380. DeakT QuinnM CidlowskiJA VictoriaNC MurphyAZ SheridanJF Neuroimmune mechanisms of stress: sex differences, developmental plasticity, and implications for stress-related disease Stress 2015 18 4 367 380 10.3109/10253890.2015.1053451481331026176590 Search in Google Scholar

[26] Formichi P, Radi E, Battisti C, Di Maio G, Muresanu D, Federico A. Cerebrolysin administration reduces oxidative stress-induced apoptosis in lymphocytes from healthy individuals. J Cell Mol Med. 2012;16(11):2840–2843. FormichiP RadiE BattistiC Di MaioG MuresanuD FedericoA Cerebrolysin administration reduces oxidative stress-induced apoptosis in lymphocytes from healthy individuals J Cell Mol Med 2012 16 11 2840 2843 10.1111/j.1582-4934.2012.01615.x411825222882711 Search in Google Scholar

[27] Hallberg M. Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors. Med Res Rev. 2015;35(3):464–519 HallbergM Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors Med Res Rev 2015 35 3 464 519 10.1002/med.2132324894913 Search in Google Scholar

[28] Semmens DC, Elphick MR. The evolution of neuropeptide signalling: insights from echinoderms. Brief Funct Genomics. 2017;16(5):288–298. SemmensDC ElphickMR The evolution of neuropeptide signalling: insights from echinoderms Brief Funct Genomics 2017 16 5 288 298 10.1093/bfgp/elx005586047128444138 Search in Google Scholar

[29] Yugan YL, Sotskaya YA, Chabarova AB. The effectiveness of the modern immunoactive preparation immunofan for medical rehabilitation of patients with nonalcoholic steatohepatitisis against neurocirculatory dystonia, after infectious mononucleosis. Lik Sprava. 2015; (5–6):132–139. YuganYL SotskayaYA ChabarovaAB The effectiveness of the modern immunoactive preparation immunofan for medical rehabilitation of patients with nonalcoholic steatohepatitisis against neurocirculatory dystonia, after infectious mononucleosis Lik Sprava 2015 5–6 132 139 Search in Google Scholar